New RNA Regulatory Network Identified in Colorectal Cancer Progression and Immune Response

Researchers have identified a key RNA-driven regulatory network that influences colorectal cancer progression and immune response, offering new therapeutic targets to improve treatment resistance. Learn more about this groundbreaking study.
Recent research led by Prof. Gu Hongcang and Zhang Fan at the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has uncovered a crucial RNA-driven regulatory network influencing colorectal cancer (CRC) development and immune system interaction. Through comprehensive multi-omics analysis—integrating transcriptomic, proteomic, and metabolomic data—scientists identified key molecular alterations distinguishing CRC tissues from normal counterparts, including 1,394 differentially expressed long non-coding RNAs (lncRNAs), 2,788 mRNAs, 548 proteins, and 91 metabolites.
Among these, a particular lncRNA named lncRNA 60967.1 stood out as a central regulator. It was significantly downregulated in CRC cell lines and patient samples. Functional studies demonstrated that restoring lncRNA 60967.1 reactivates the tumor suppressor gene PLCD4 and increases all-trans retinoic acid (ATRA) levels, which in turn promotes apoptosis through interferon gamma pathways. This enhancement of immune responses partially mitigates the resistance of CRC cells to immune attack.
In vivo experiments in mouse models showed that overexpression of lncRNA 60967.1 boosted immune cell infiltration into tumors and significantly inhibited tumor growth, especially when combined with anti-PD-1 immunotherapy. These findings suggest that lncRNA 60967.1 influences both tumor progression and immune response mechanisms, presenting a promising therapeutic target.
The research, published in Molecular Cancer, highlights the importance of the newly identified lncRNA 60967.1–PLCD4–ATRA axis. Targeting this pathway could help overcome resistance in CRC treatments and improve immunotherapy efficacy. This discovery advances our understanding of CRC's molecular complexity and opens new avenues for precision medicine strategies in combating this disease.
Source: https://medicalxpress.com/news/2025-07-uncovers-key-rna-driven-network.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Research Confirms Daily Aspirin Offers No Long-Term Heart Disease Prevention in Older Adults
Recent research confirms that daily low-dose aspirin provides no long-term cardiovascular protection for healthy older adults and increases bleeding risks, suggesting a reevaluation of its use for primary prevention.
Global Study Highlights Gender Variations in Antimicrobial Resistance
A groundbreaking global study uncovers important gender differences in antimicrobial resistance, highlighting variations in resistance genes across countries and age groups, with significant implications for public health strategies.
New Study Reveals How Brain Cells Respond Differently to Social and Stressful Stimuli
Recent research uncovers how different brain cells, including oxytocin neurons and astrocytes, respond uniquely to social interactions and stress, highlighting potential pathways for enhancing social resilience and stress management.
Innovative Approaches to Primary Care for Individuals Living with Obesity
A Drexel University study co-designed an ideal primary care experience for individuals with obesity, emphasizing empathy, respect, and inclusivity to improve healthcare engagement and reduce stigma.



